DRTG announced that the transaction of transferring its 13% equity stake in China-U.S. Tianjin Sihua Pharmaceutical Co., Ltd. to Helion Limited has been completed. After the transaction, the company's equity stake in Tianjin Sihua has changed from 25% to 12%, and it remains a shareholder of Tianjin Sihua
